Original Research

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al

ClinicoEconomics and Outcomes Research 2011, 3:19-27

Published Date: 25 January 2011